ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP.

November 16, 2007

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

NCI-Approved Clinical Trials

August 31, 2001